Scimed Biotechnologies, s.r.o. is a Czech biotechnology company founded in 2018, based in Prague. We deal with research in the field of cell therapy and regenerative medicine, as well as laboratory diagnostics detecting the presence of a new type of coronavirus (SARS-COV-2) or COVID 19.
Since 2020, we have also been a non-governmental medical facility and one of the very first laboratories authorized by the State Institute of Public Health (SZÚ) for the diagnosis of SARS-COV-2. We operate more than 10 permanent sampling points in the Czech Republic and provide mobile testing in companies, municipalities, schools and other institutions.